Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • pkstarstorm05
    Member
    • Jun 2014
    • 14

    #1

    Interpreting bizarre cross-correlation results

    Hi all,

    I'm working with an Estrogen Receptor Chip-seq data set and I'm using the SPP phantom peak quality tools to calculate cross correlation and the plots produced look very bizarre compared to the ENCODE standards (from this paper).

    ChIP-seq guidelines and practices of the ENCODE and modENCODE consortia
    (DOI: 10.1101/gr.136184.111)

    This study is following a study using tissue derived from mouse uterus where they treated with E2 and performed ChIP for ER alpha and Pol2.
    (DOI: 10.1210/me.2011-1311)

    I've downloaded their datasets from SRA and performed the same cross correlation analysis and - to put it shortly - their data looks normal, whereas our data looks kind of crazy. The mapping was performed using the same programs and my reads were quality filtered and the mapping results look the same. The SRA data was mapping using the --sra-acc option in hisat2, so no filtering was necessary.

    I've linked our cross correlation plots for reference.

    Plot 1:


    Plot 2:


    Published Uterine ChIPseq data from SRA:
    ER ChIP no treatment


    I was hoping someone might be able to help me interpret what I'm looking at... and whether or not the data set is still usable for analysis. In particular, what would cause so many jagged peaks across the entire plot??

    Thanks in advance,

    Paul

Latest Articles

Collapse

  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM
  • SEQadmin2
    New Genomics Technologies Take Aim at Long-Standing Limits
    by SEQadmin2


    Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

    We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
    ...
    09-28-2026, 10:25 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
24 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
20 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-15-2026, 10:52 AM
0 responses
36 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-14-2026, 05:39 AM
0 responses
42 views
0 reactions
Last Post SEQadmin2  
Working...